Business profile

Leo Pharma Oy

Leo Pharma Oy's registered office is Vanda. It is a limited company. The company was established on 1990-09-26. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €10,943,342 and operating profit was €342,397.

Business ID 0807589-1ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
0807589-1
Sector
Wholesale of pharmaceutical goods
Municipality
Vanda
Company form
Limited company
Registration date
1990-09-26
Business ID registration date
1990-08-21
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Karhumäentie 3, 01530, Vanda

Phone: +358207218440Source observation

Email: [email protected]Source observation

Website: https://www.leo-pharma.fiSource observation

People and decision-makers

Anja Cecilie VerhaugToimitusjohtaja (5/2022)

About Leo Pharma Oy

Financial position and key figures for the company.

Leo Pharma Oy's location municipality is Vanda. It is a limited company. The company was established on 1990-09-26. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €10,943,342 and operating profit was €342,397. The latest retained financial statement for 2025-12-31 shows revenue of €10,943,342 and profit for the financial year of €242,544. Based on the latest retained statement, revenue growth was +0.0%, operating margin was +3.1%, and equity ratio was +42.9%.

Auxiliary business names

Public alternate names materialized from source observations.

LEO Animal HealthLEO Quality CareLEO Specific-dietsSpecicare

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth0.0%
Operating margin3.1%
Equity ratio42.9%
Balance-sheet contextLatest financial period
Employees4Previous: 4
Revenue trend4 periods
€9,537,165
2022-12-31
€10,839,675
2023-12-31
€10,943,342
2024-12-31
€10,943,342
2025-12-31
Operating profit (loss) trend4 periods
€299,387
2022-12-31
€333,696
2023-12-31
€342,397
2024-12-31
€342,397
2025-12-31
Profit (loss) for the financial year trend4 periods
€193,578
2022-12-31
€223,293
2023-12-31
€242,544
2024-12-31
€242,544
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioSatisfactory
54/100 · Improving
42.9 %2023-12-31: 34.3 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2024-12-31: Ei saatavilla
Operating profit marginSatisfactory
58/100 · Stable
3.1 %2024-12-31: 3.1 %
Ratio history
Ratio2022-12-312023-12-312024-12-312025-12-31
Equity ratio19.7 %34.3 %-42.9 %
Current ratio----
Operating profit margin3.1 %3.1 %3.1 %3.1 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID0807589-1
VAT IDFI08075891
EU IDFIFPRO.0807589-1
MunicipalityVanda
Current registered entries
1990-08-01Registered in Tax Administration (Employer Register)
1990-08-21Registered in Tax Administration (Tax Administration)
1990-09-26Registered in Patent and Registration Office (Trade Register)
1994-06-01VAT-liable for business activity in Tax Administration (VAT Register)
1995-03-01Registered in Tax Administration (Prepayment Register)

Responsible people

Public role relationships materialized from source observations.

Anja Cecilie VerhaugToimitusjohtaja (5/2022)Sources: 3 · Confidence: 76%
Dilay KücükkoseHallitus: puheenjohtajaSources: 1 · Confidence: 76%
Verhaug Anja CecilieVarsinainen jäsenSources: 1 · Confidence: 72%
Jakob GregersenHallitus: varajäsenSources: 1 · Confidence: 76%
Antti OjalaPäävastuullinen tilintarkastajaSources: 1 · Confidence: 76%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A3
GoodLeo Pharma Oy
Model score73/100
Assessment confidenceMedium
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
4 comparable periods
RevenueStable
ProfitabilityStable
SolvencyNot enough history
LiquidityNot enough history
Peer comparisonNational Tier 1 comparisonDescriptive comparison – does not change the model score.
321 peers
Solvency37%
Below 63% of peers
Profitability59%
Better than 59% of peers
Revenue growth50%
Close to the peer-group midpoint
Supporting factors
  • Strong equity ratio
  • Active registered status
  • A newer financial statement filing has been reported
Risk factors to note
  • Elevated industry distress context
Automatic model gradeA3
Automatic model snapshot2026-09-16
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
45/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityVakiintunut
90/100

The company has about 36 years of registry continuity.

Registry and status signalsVakaa
86/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
16 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.

Registry timeline

Trade register notifications shown on a timeline.

34 register eventsLatest event: 2026-07-07

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Leo Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.